VF
WGS icon

Virtu Financial’s GeneDx Holdings WGS Stock Holding History

Virtu Financial’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,117
Closed -$767K – 2300
2025
Q3 		$767K Buy
+7,117
New +$775K 0.04% 405
2025
Q2 		– Sell
-3,622
Closed -$321K – 2080
2025
Q1 		$321K Buy
+3,622
New +$314K 0.02% 643
2022
Q3 		– Sell
-1,250
Closed -$52K – 2283
2022
Q2 		$52K Buy
1,250
+802
+179% +$54.4K ﹤0.01% 1119
2022
Q1 		$45K Sell
448
-709
-61% -$78.8K ﹤0.01% 1164
2021
Q4 		$170K Buy
+1,157
New +$258K 0.02% 894
2021
Q3 		– Sell
-1,438
Closed -$665K – 2009
2021
Q2 		$665K Buy
+1,438
New +$617K 0.06% 348
2021
Q1 		– Sell
-350
Closed -$128K – 2073
2020
Q4 		$128K Buy
+350
New +$122K 0.01% 994

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Virtu Financial's WGS Position: Q4 2025 in Review

Virtu Financial sold out of GeneDx Holdings (WGS) in Q4 2025, closing a stake of 7,117 shares — an estimated $767K sold.

Virtu Financial first reported a position in WGS in Q4 2020 and held it in 7 quarters. The position peaked at $767K in Q3 2025. 286 funds tracked by Wall St. Rank hold WGS as of Q4 2025.

  • Virtu Financial reported no remaining GeneDx Holdings position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 7,117 GeneDx Holdings shares in Q4 2025, an estimated $767K.
  • Virtu Financial first reported a position in GeneDx Holdings in Q4 2020 and held it in 7 quarters.
  • Virtu Financial's GeneDx Holdings position peaked at $767K in Q3 2025.
  • 286 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.